Pay-for-Performance & Incentives

Synthesis: The past week has seen accelerated momentum in pay-for-performance and incentive-based models, notably with the launch of the USA Value-Based Pharmacist Quality Rewards Program targeting chronic condition management, and a parallel initiative by Humana in Ohio incentivizing pharmacists based on patient outcomes (Business Wire). Under the leadership of President Donald J. Trump and HHS Secretary Robert F. Kennedy Jr., HHS and CMS have emphasized expanding value-based initiatives. Dr. Mehmet Oz, the current CMS Administrator, indicated that the agency is prioritizing pharmacist involvement in chronic disease management across Medicare and Medicaid, aligning with the new program’s goals. These moves reflect the administration's broader push to incentivize better health outcomes by tying payments to quality metrics, continuing to reshape provider incentives in the post-fee-for-service era.